Inventor · disambiguated record
Marguerite Mensonides-Harsema
Also filed as: MENSONIDES-HARSEMA MARGUERITE · MENSONIDES-HARSEMA MARGUÉRITE · MENSONIDES-HARSEMA MARGUÉRITE MASCHA
7 granted patents·9 pending applications·13 citations·filing 2003–2024
78Inventor score
Files withMEDAC GES FUER KLINISCHE SPEZIALPRAEPARATE MBH5ASTRAZENECA AB4ERIKSSON TOMAS3GIBSON SCOTT1HOSSAIN NAFIZAL1
Top patents by PatentIndex Score
16 records- 0182US11690857B2Pharmaceutical composition for oral administration containing sulfasalazine and/or a sulfasalazine organic salt, production process and useMEDAC GES FUER KLINISCHE SPEZIALPRAEPARATE MBH·Filed 2018·Granted Jul 4, 2023·2 cites·25 claims
- 0282US11304936B2Sulfasalazine salts, production processes and usesMEDAC GES FUER KLINISCHE SPEZIALPRAEPARATE MBH·Filed 2018·Granted Apr 19, 2022·4 cites·10 claims
- 0379US10703723B2Prodrugs of sulfasalazine, pharmaceutical compositions thereof and their use in the treatment of autoimmune diseaseTRULY TRANSLATIONAL SWEDEN AB·Filed 2018·Granted Jul 7, 2020·5 cites·20 claims
- 0474US2024423966A1Sulfasalazine salts, production processes and usesMEDAC GES FUER KLINISCHE SPEZIALPRAEPARATE MBH·Filed 2024·Application pending·0 cites
- 0569US12274706B2Pharmaceutical composition for oral administration containing sulfasalazine and/or a sulfasalazine organic salt, production process and useMEDAC GES FUER KLINISCHE SPEZIALPRAEPARATE MBH·Filed 2023·Granted Apr 15, 2025·0 cites·14 claims
- 0669US12128037B2Sulfasalazine salts, production processes and usesMEDAC GES FUER KLINISCHE SPEZIALPRAEPARATE MBH·Filed 2022·Granted Oct 29, 2024·0 cites·6 claims
- 0760US7498338B2CompoundsASTRAZENECA AB·Filed 2004·Granted Mar 3, 2009·1 cites·11 claims
- 0860US7449475B2Tricyclic spiropiperidines or spiropyrrolidinesASTRAZENECA AB·Filed 2003·Granted Nov 11, 2008·1 cites·12 claims
- 0956US2009062322A1Novel Tricyclic Spiropiperidines or SpiropyrrolidinesASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1052US2024327331A1Esters of 7-cooh cbd derivatives and their use as prevention, prophylaxis of progression, and/or treatment of neurogenerative diseasesReceptor Pharma INC·Filed 2022·Application pending·0 cites
- 1152US2009176815A1Novel Tricyclic Spiropiperidine Compounds, Their Synthesis and Their Uses as Modulators of Chemokine Receptor ActivityERIKSSON TOMAS·Filed 2009·Application pending·0 cites
- 1246US2008167332A1Novel Compounds 243GIBSON SCOTT·Filed 2007·Application pending·0 cites
- 1344US2007123543A1Novel compoundsHOSSAIN NAFIZAL·Filed 2004·Application pending·0 cites
- 1441US2011124613A1Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and AsthmaERIKSSON TOMAS·Filed 2008·Application pending·0 cites
- 1541US2011136843A1Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and AsthmaERIKSSON TOMAS·Filed 2008·Application pending·0 cites
- 1633US2008194632A1Novel Piperidine Derivatives as Chemokine Receptor Modulators Useful for the Treatment of Respiratory DiseasesASTRAZENECA AB·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →